마드리갈 파마슈티컬스, Inc.
US ˙ NasdaqGS ˙ US5588681057

SecurityMDGL / Madrigal Pharmaceuticals, Inc.
InstitutionONEQ - Fidelity Nasdaq Composite Index Tracking Stock
Latest Disclosed Ownership4,961 shares
Latest Disclosed Value $ 1,365,564
ONEQ - Fidelity Nasdaq Composite Index Tracking Stock reports 7.15% decrease in ownership of MDGL / Madrigal Pharmaceuticals, Inc.

On July 24, 2025 - ONEQ - Fidelity Nasdaq Composite Index Tracking Stock filed a NPORT-P form disclosing ownership of 4,961 shares of Madrigal Pharmaceuticals, Inc. (US:MDGL) valued at $1,365,565 USD as of May 31, 2025. The entity filed a previous NPORT-P on April 25, 2025 disclosing 5,343 shares of Madrigal Pharmaceuticals, Inc.. This represents a change in shares of -7.15% during the quarter. The current value of the position is $2,415,908 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-07-24 2025-05-31 NP MADRIGAL PHARMACEUTICALS EC US5588681057 4,961 -382 -7.15 1,366 -25.12 0.0181
2025-04-25 2025-02-28 NP MADRIGAL PHARMACEUTICALS EC US5588681057 5,343 -98 -1.80 1,823 2.13 0.0246
2025-01-27 2024-11-30 NP MADRIGAL PHARMACEUTICALS EC US5588681057 5,441 -77 -1.40 1,786 30.96 0.0242
2024-10-29 2024-08-31 NP MADRIGAL PHARMACEUTICALS EC US5588681057 5,518 -800 -12.66 1,364 -8.65 0.0202
2024-07-26 2024-05-31 NP MADRIGAL PHARMACEUTICALS EC US5588681057 6,318 -172 -2.65 1,492 -2.61 0.0236
2024-04-24 2024-02-29 NP MADRIGAL PHARMACEUTICALS EC US5588681057 6,490 93 1.45 1,533 17.85 0.0256
2024-01-24 2023-11-30 NP MADRIGAL PHARMACEUTICALS EC US5588681057 6,397 -430 -6.30 1,301 5.86 0.0249
2023-10-27 2023-08-31 NP MADRIGAL PHARMACEUTICALS EC US5588681057 6,827 90 1.34 1,229 -34.51 0.0240
2023-07-26 2023-05-31 NP MADRIGAL PHARMACEUTICALS EC US5588681057 6,737 -665 -8.98 1,876 -6.53 0.0405
2023-04-27 2023-02-28 NP MADRIGAL PHARMACEUTICALS EC US5588681057 7,402 180 2.49 2,006 296.44 0.0491
2023-01-26 2022-11-30 NP MADRIGAL PHARMACEUTICALS EC US5588681057 7,222 188 2.67 506 -0.20 0.0127
2022-10-26 2022-08-31 NP MADRIGAL PHARMACEUTICALS EC US5588681057 7,034 7,034 507 0.0127
2022-07-29 2022-05-31 NP MADRIGAL PHARMACEUTICALS EC US5588681057 0 -10 -100.00 0
2022-04-28 2022-02-28 NP MADRIGAL PHARMACEUTICALS EC US5588681057 10 -8,846 -99.89 1 -100.00 0.0000
2022-01-25 2021-11-30 NP MADRIGAL PHARMACEUTICALS EC US5588681057 8,856 215 2.49 732 2.38 0.0153
2021-10-26 2021-08-31 NP MADRIGAL PHARMACEUTICALS EC US5588681057 8,641 4,649 116.46 715 59.60 0.0157
2021-07-22 2021-05-31 NP MADRIGAL PHARMACEUTICALS EC US5588681057 3,992 0 0.00 448 -7.25 0.0111
2021-04-23 2021-02-28 NP MADRIGAL PHARMACEUTICALS EC US5588681057 3,992 -3,353 -45.65 484 -43.64 0.0126
2021-01-20 2020-11-30 NP MADRIGAL PHARMACEUTICALS EC US5588681057 7,345 3,592 95.71 858 112.13 0.0256
2020-10-16 2020-08-31 NP MADRIGAL PHARMACEUTICALS EC US5588681057 3,753 941 33.46 404 23.93 0.0125
2020-07-20 2020-05-31 NP MADRIGAL PHARMACEUTICALS EC US5588681057 2,812 2,812 326 0.0127
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.